Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Giaccone

Showing results (51-60 of 380) with videos related to

Pageof 38
Sort By:
Nature Clinical Practice. Oncology|November 5, 2005
EGFR inhibitors: what have we learned from the treatment of lung cancer?Giuseppe Giaccone, Jose Antonio Rodriguez
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
The role of new agents in the treatment of non-small cell lung cancerLinda E Bröker, Giuseppe Giaccone
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Update on the systemic treatment of lung cancerGiuseppe Giaccone, Egbert F Smit
European Journal of Cancer (Oxford, England : 1990)|September 23, 2006
Biology and management of malignant pleural mesotheliomaPaolo A Zucali, Giuseppe Giaccone
Mediastinum (Hong Kong, China)|February 4, 2022
Best practices and guidelines for the management of thymic epithelial tumorsGiuseppe Giaccone, Jonathan W Lischalk
The Oncologist|December 6, 2003
Small-molecule epidermal growth factor receptor tyrosine kinase inhibitorsMaarten L Janmaat, Giuseppe Giaccone
Expert Opinion on Biological Therapy|August 6, 2010
The role of talactoferrin alpha in the treatment of non-small cell lung cancerRonan J Kelly, Giuseppe Giaccone
Journal of Molecular Medicine (Berlin, Germany)|May 24, 2014
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancerArjan Gower, Yisong Wang, Giuseppe Giaccone
Frontiers in Oncology|April 12, 2021
Challenges in Diversity, Equity, and Inclusion in Research and Clinical OncologyWafik S El-Deiry, Giuseppe Giaccone
Nature Cancer|June 16, 2025
Advancing therapeutics in small-cell lung cancerAnish Thomas, Chirayu Mohindroo, Giuseppe Giaccone
Pageof 38

Showing results (51-60 of 380) with videos related to

Sort By:
Pageof 38
Nature Clinical Practice. Oncology|November 5, 2005
EGFR inhibitors: what have we learned from the treatment of lung cancer?Giuseppe Giaccone, Jose Antonio Rodriguez
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
The role of new agents in the treatment of non-small cell lung cancerLinda E Bröker, Giuseppe Giaccone
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Update on the systemic treatment of lung cancerGiuseppe Giaccone, Egbert F Smit
European Journal of Cancer (Oxford, England : 1990)|September 23, 2006
Biology and management of malignant pleural mesotheliomaPaolo A Zucali, Giuseppe Giaccone
Mediastinum (Hong Kong, China)|February 4, 2022
Best practices and guidelines for the management of thymic epithelial tumorsGiuseppe Giaccone, Jonathan W Lischalk
The Oncologist|December 6, 2003
Small-molecule epidermal growth factor receptor tyrosine kinase inhibitorsMaarten L Janmaat, Giuseppe Giaccone
Expert Opinion on Biological Therapy|August 6, 2010
The role of talactoferrin alpha in the treatment of non-small cell lung cancerRonan J Kelly, Giuseppe Giaccone
Journal of Molecular Medicine (Berlin, Germany)|May 24, 2014
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancerArjan Gower, Yisong Wang, Giuseppe Giaccone
Frontiers in Oncology|April 12, 2021
Challenges in Diversity, Equity, and Inclusion in Research and Clinical OncologyWafik S El-Deiry, Giuseppe Giaccone
Nature Cancer|June 16, 2025
Advancing therapeutics in small-cell lung cancerAnish Thomas, Chirayu Mohindroo, Giuseppe Giaccone
Pageof 38